AI-guided pathology analysis can help predict immunotherapy response in rare cancers

AI-guided pathology analysis can help predict immunotherapy response in rare cancers. Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based analysis of tumor biopsies can predict responses to immunotherapy in a study of patients with rare cancers, published in the Journal for ImmunoTherapy of Cancer.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based analysis of tumor biopsies can predict responses to immunotherapy in a study of patients with rare cancers, published in the Journal for ImmunoTherapy of Cancer.

• Ponto de atenção: guided.
• Ponto de atenção: pathology.
• Ponto de atenção: analysis.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.